USE OF VWF-CONTAINING CONCENTRATE AS MEDICAL TREATMENT APPLIED BY COMBINING WITH ANTI-THROMBOTIC AND THROMBUS-DISSOLVING MEDICAL TREATMENT

Japanese Patent JPH08208504

A

PROBLEM TO BE SOLVED: To obtain a preparation acting as an alexipharmac for reducing the danger of hemorrhage caused by the administration of an antithrombotic medicine or a thrombolytic medicine and not impairing the antithrombotic or thrombolytic effect by using von Willebrand factor of soluble serum protein. SOLUTION: This preparation contains von Willebrand factor (vWF) or a fragment having the vWF activity as an active ingredient. An antithrombotic medicine capable of being combined with the preparation includes synthetic thrombin-inhibiting agents such as heparin or γ-hirudine. The thrombolytic medicine capable of being combined with the preparation and the antithrombotic medicine preferably comprises streptokinase, plasminogen activators, and their derivatives. The preparation is preferably administered, when or after the antithrombotic medicine is administered and lysed.

JP5770775	Stable pharmaceutical composition containing factor VIII
JP2023506171	Gene therapy for hemophilia A using a viral vector encoding an upregulated recombinant FVIII variant
WO/2022/226048	IMMUNE TOLERANCE INDUCTION AND ERADICATION OF ANTI-DRUG ANTIBODIES (ADA) TO THERAPEUTIC FACTOR VIII

MARUTEIN REERUSU
GEERUHARUTO DEIKUNAITE

JP27078595A

August 13, 1996

October 19, 1995

Click for automatic bibliography generation  

BEHRINGWERKE AG

A61K38/37; A61K38/41; A61K38/43; A61K38/55; A61K38/00; A61P7/00; A61P7/02; A61P7/04; (IPC1-7): A61K38/00; A61K38/43

Chika Takagi (2 outside)

Previous Patent: PREVENTION AND TREATMENT OF CANCER AND AIDS WITH FUNGUS

Next Patent: COMPOSITION FOR LOCALITY CONTAINING SUBSTANCE P ANTAGONIST